本页面由Tiger Trade Technology Pte. Ltd.提供服务

ADC Therapeutics SA

1.86
+0.13007.51%
盘后:1.85-0.0100-0.54%19:40 EDT
成交量:159.31万
成交额:280.57万
市值:2.38亿
市盈率:-2.56
高:1.87
开:1.70
低:1.64
收:1.73
52周最高:4.98
52周最低:0.7796
股本:1.28亿
流通股本:8,856.21万
量比:0.59
换手率:1.80%
股息:- -
股息率:- -
每股收益(TTM):-0.7271
每股收益(LYR):-1.1224
净资产收益率:-705.53%
总资产收益率:-19.57%
市净率:-1.04
市盈率(LYR):-1.66

数据加载中...

2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/12

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/10/13

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/09/21

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/21

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/21

招股说明书

F-1 - Registration statement for certain foreign private issuers
2020/09/14

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/08/18

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/05/29

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/05/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/05/14

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/05/12

SEC问询函

CORRESP [Cover] - Correspondence
2020/05/12

SEC问询函

CORRESP [Cover] - Correspondence
2020/05/11

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/04/28

SEC问询函

CORRESP [Cover] - Correspondence
2020/04/27

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/04/24

招股说明书

F-1 - Registration statement for certain foreign private issuers
2019/10/03

SEC问询函

CORRESP [Cover] - Correspondence
2019/09/30

SEC问询函

CORRESP [Cover] - Correspondence